Bupropion Hydrochloride
- Product NDC
- 70934-985
- 11-digit product format
- 709340985
- Labeler code
- 70934
- Product ID
- 70934-985_e61015a3-f5c0-6489-e053-2995a90afa1e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bupropion hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA211347
- Marketing category
- ANDA
- Marketing start
- 2022-07-01
- Marketing end
- 2023-11-30
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-985-30 | 70934098530 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-985-30) | 2022-08-18 | 2023-11-30 | No | No | Current |
| 70934-985-60 | 70934098560 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-985-60) | 2022-07-01 | 0000-00-00 | No | No | Current |
| 70934-985-90 | 70934098590 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-985-90) | 2022-07-01 | 0000-00-00 | No | No | Current |
| 70934-985-96 | 70934098596 | 180 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-985-96) | 2022-08-11 | 2023-11-30 | No | No | Current |